Get started
Author

Louise Catherine Connell

Observed names: Connell, L, L. C. Connell, L. Connell, L.C. Connell, Louise C Connell, Louise C. Connell, Louise Connell
Observed institutions: Memorial Sloan Kettering Cancer Center, University of Patras, Cornell University, Concord Repatriation General Hospital, Cork University Hospital, Mater Misericordiae University Hospital, Mercy University Hospital, St. Vincent's University Hospital, Hospital Sírio-Libanês, Erasmus MC Cancer Institute, St. James's Hospital, Weill Cornell Medicine
ORCID: 0000-0002-3193-4629
Observed ORCID: 0000-0002-3193-4629
OpenAlex ID: A5024581698
Toxicities of the anti-PD-1 and anti-PD-L1 immune checkpoint antibodies
2015 · J. Naidoo, D.B. Page, et al. · Annals of Oncology · 1,470
The Rising Incidence of Younger Patients With Colorectal Cancer: Questions About Screening, Biology, and Treatment
2017 · Louise C. Connell, José Mauricio Mota, et al. · Current Treatment Options in Oncology · 229
A Comprehensive Comparison of Early-Onset and Average-Onset Colorectal Cancers
2021 · Andrea Cercek, Walid K Chatila, et al. · JNCI Journal of the National Cancer Institute · 207
Corrections to “Toxicities of the anti-PD-1 and anti-PD-L1 immune checkpoint antibodies”
2016 · J. Naidoo, D.B. Page, et al. · Annals of Oncology · 177
PDF
Phase II Single-arm Study of Durvalumab and Tremelimumab with Concurrent Radiotherapy in Patients with Mismatch Repair–proficient Metastatic Colorectal Cancer
2021 · Neil H. Segal, Andrea Cercek, et al. · Clinical Cancer Research · 84
Advanced Hepatocellular Cancer: the Current State of Future Research
2016 · Louise C. Connell, James J. Harding, et al. · Current Treatment Options in Oncology · 66
Response rates of hepatic arterial infusion pump therapy in patients with metastatic colorectal cancer liver metastases refractory to all standard chemotherapies
2016 · Andrea Cercek, Taryn M. Boucher, et al. · Journal of Surgical Oncology · 61
Intrahepatic Cholangiocarcinoma with Lymph Node Metastasis: Treatment-Related Outcomes and the Role of Tumor Genomics in Patient Selection
2021 · Joshua S. Jolissaint, Kevin C. Soares, et al. · Clinical Cancer Research · 54
Characterization and Clinical Outcomes of DNA Mismatch Repair–deficient Small Bowel Adenocarcinoma
2020 · Alicia Latham, Jinru Shia, et al. · Clinical Cancer Research · 48
PDF
Combined intrahepatic cholangiocarcinoma and hepatocellular carcinoma
2016 · Louise C. Connell, James J. Harding, et al. · Chinese Clinical Oncology · 45
Development and Assessment of a Clinical Calculator for Estimating the Likelihood of Recurrence and Survival Among Patients With Locally Advanced Rectal Cancer Treated With Chemotherapy, Radiotherapy, and Surgery
2021 · Martin R. Weiser, Joanne F. Chou, et al. · JAMA Network Open · 31
PDF
Early Specialty Palliative Care
2014 · Jodie E Battley, Louise C Connell, et al. · New England Journal of Medicine · 24
Relevance of CEA and LDH in relation to KRAS status in patients with unresectable colorectal liver metastases
2016 · Louise C. Connell, Taryn M. Boucher, et al. · Journal of Surgical Oncology · 18
Genomic stratification beyond Ras/B‐Raf in colorectal liver metastasis patients treated with hepatic arterial infusion
2019 · J. Joshua Smith, Walid K. Chatila, et al. · Cancer Medicine · 13
PDF
A Randomized Phase II Trial of Adjuvant Hepatic Arterial Infusion and Systemic Therapy With or Without Panitumumab After Hepatic Resection of KRAS Wild-type Colorectal Cancer
2021 · Nancy E. Kemeny, Joanne F. Chou, et al. · Annals of Surgery · 12
Voxel-Based Dosimetry Predicts Local Tumor Progression Post 90Y Radiation Segmentectomy of Colorectal Liver Metastases
2024 · Platon M. Dimopoulos, Vlasios S. Sotirchos, et al. · Clinical Nuclear Medicine · 11
Hepatic disease control in patients with intrahepatic cholangiocarcinoma correlates with overall survival
2023 · Kevin C. Soares, Joshua S. Jolissaint, et al. · Cancer Medicine · 11
PDF
Intraarterial Chemotherapy for Liver Metastases
2020 · Louise C. Connell, Nancy E. Kemeny · Surgical Oncology Clinics of North America · 11
Long-term outcomes in patients with advanced intrahepatic cholangiocarcinoma treated with hepatic arterial infusion chemotherapy
2024 · Darren Cowzer, Kevin Soares, et al. · JNCI Journal of the National Cancer Institute · 9
PDF
Are Dose-Dense and Triplet Chemotherapy Regimens Optimal Adjuvant Therapy in the Majority of Women With Node-Positive Early Breast Cancer?
2014 · Eugene J. Moylan, Louise C. Connell, et al. · Journal of Clinical Oncology · 7
Tumor Absorbed Dose Predicts Survival and Local Tumor Control in Colorectal Liver Metastases Treated with 90Y Radioembolization
2025 · Marios-Platon Dimopoulos, Vlasios S. Sotirchos, et al. · CardioVascular and Interventional Radiology · 6
Adjuvant Cytotoxic Chemotherapy may not be Associated with a Survival Advantage for Resected Intrahepatic Cholangiocarcinoma
2025 · Jeremy Sharib, Kristen E. Rhodin, et al. · Annals of Surgical Oncology · 6
Lymph node ratio prognosticates overall survival in patients with stage IV colorectal cancer
2024 · K. Naidu, P. H. Chapuis, et al. · Techniques in Coloproctology · 5
PDF
Primary Clonal Loss of Mismatch Repair Protein on Immunohistochemistry: A Pattern of Abnormality That Warrants Genetic Workup
2022 · Christine Orr, Chiyun Wang, et al. · JCO Precision Oncology · 5
Impact of Primary Tumor Laterality on Adjuvant Hepatic Artery Infusion Pump Chemotherapy in Resected Colon Cancer Liver Metastases: Analysis of 487 Patients
2020 · Sepideh Gholami, Susan Stewart, et al. · Annals of Surgical Oncology · 5
Works count: 103
Citation count: 2,669
H-index: 13
I10-index: 18
Year
Topic
Type